Publications by authors named "Bayram Dogan"

Claim this Profile
T
The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study.
Doğan Bayram, Efe Cem Erdat, Sema Nur Özsan Çelebi, Serap Türk, Serhat Sekmek

J Hepatocell Carcinoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma.
Doğan Bayram, Safa Can Efil, Serap Türk, Oğuz Kara, Serhat Sekmek

Clin Med Insights Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.
Doğan Bayram, Oznur Bal, Efe Cem Erdat, Serhat Sekmek, Saliha Yılmaz

Diagnostics (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.
Ogur Karhan, Serdar İleri, Zuhat Urakçı, Yasin Sezgin, Ümit Yıldırım

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG).
Fatih Kus, Hasan Cagri Yildirim, Dogan Bayram, Oznur Bal, Gokhan Sahin

J Chemother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Clinical and Morphometric Parameters on Hematopoietic Engraftment Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Germ Cell Tumors.
Ömer Faruk Kuzu, Nuri Karadurmuş, Ahmet Gazi Acar, Nebi Batuhan Kanat, Çağlar Köseoğlu

Medicina (Kaunas)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis.
Emre Hafızoğlu, Murat Bardakçı, Yakup Ergun, Irfan Karahan, Doğan Bayram, Dogan Uncu

Diagnostics (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Artificial Intelligence (ChatGPT-4o) in Supporting Tumor Board Decisions.
Berkan Karabuğa, Cengiz Karaçin, Mustafa Büyükkör, Doğan Bayram, Ergin Aydemir

J Clin Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HALP score as a prognostic factor in metastatic biliary cancer.
İsmet Seven, İrfan Karahan, Fahriye Tuğba Köş, Doğan Bayram, Serhat Sekmek

Clin Transl Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of HER2 Positivity in Endometrium Cancer.
Serhat Sekmek, Dogan Bayram, Irfan Karahan, Ismet Seven, Perihan Perkin, Dogan Uncu

Oncol Res Treat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective Cohort.
Emre Hafızoğlu, Murat Bardakçı, Yakup Ergun, Irfan Karahan, Derya Demirtaş Esmer, Dogan Uncu

Medicina (Kaunas)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letrozole-induced reversible acute heart failure.
Serhat Sekmek, Dogan Bayram, Ismet Seven, Perihan Perkin, Oznur Bal

J Oncol Pharm Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score.
Doğan Bayram, Öznur Bal, Kemal Karaman, Murat Bardakçı, Derya Demirtaş Esmer

Curr Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.
Gökhan Uçar, Serhat Sekmek, İrfan Karahan, Yakup Ergün, Özlem Aydın İsak

Oncology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab associated immune thrombocytopenia.
Perihan Perkin, Serhat Sekmek, Dogan Bayram, Fahriye Tugba Kos

J Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting hepatocellular carcinoma survival with artificial intelligence.
İsmet Seven, Doğan Bayram, Hilal Arslan, Fahriye Tuğba Köş, Kübranur Gümüşlü

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and prognostic factors in thymoma and thymic carcinoma.
Doğan Bayram, Serhat Sekmek, Mehmet Kayaalp, Murat Bardakçı, Emre Hafızoğlu, Dogan Uncu

Indian J Thorac Cardiovasc Surg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study.
Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.
Serkan Yaşar, Feride Yılmaz, Güngör Utkan, Efnan Algın, Doğan Bayram

Ann Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study.
Serhat Sekmek, Irfan Karahan, Gokhan Ucar, Furkan Ceylan, Dogan Bayram, Dogan Uncu

Clin Transl Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment.
Murat Bardakci, Hilal Karakas, Dogan Bayram, Nilufer Avci, Sait Kitapli

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib-induced heart failure.
Serhat Sekmek, Dogan Bayram, Gokhan Ucar, Burak Civelek, Fahriye Tugba Kos, Dogan Uncu

J Oncol Pharm Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of the Patients Aged Less than 40 Years Operated for a Renal Mass.
Abdullah Ilktac, Bayram Dogan, Cevper Ersoz, Ganime Coban, Senad Kalkan

J Kidney Cancer VHL· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut, Didem Taştekin, Arif Akyıldız

Oncologist· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab.
Doğan Bayram, Selin Aktürk Esen, Gökhan Uçar, Fahriye Tuğba Köş

J Oncol Pharm Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis